Skip to main content

Table 3 Associations between total adherence score, categorised according to approximate score tertiles of the study population, and risk of all cancers combined and of cancers at individual anatomical sites

From: Adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and risk of 14 lifestyle-related cancers in the UK Biobank prospective cohort study

   

Low score (0–3.5)

Mid score (3.75–4.25)

Higher score (4.5–7)

    

Model 1

Model 2

Model 1

Model 2

Cancer site

Total

Incident cancers

HR (95% CI)

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

All cancers combined

93,630

7296

1.00 (ref)

0.91 (0.86; 0.97)

0.001a

0.92 (0.87; 0.97)

0.004

0.83 (0.78; 0.87)

 < 0.001a

0.84 (0.79; 0.89)

 < 0.001a

Prostate

43,851

1818

1.00 (ref)

1.06 (0.95; 1.18)

0.275

1.06 (0.95; 1.18)

0.306

0.98 (0.87; 1.10)

0.686

0.96 (0.85; 1.08)

0.499

Breast

50,337

1438

1.00 (ref)

0.82 (0.72; 0.93)

0.003

0.82 (0.72; 0.94)

0.003

0.82 (0.73; 0.93)

0.001a

0.82 (0.73; 0.93)

0.002a

 Pre-menopausal

1108

154

1.00 (ref)

0.58 (0.38; 0.89)

0.013

0.58 (0.38; 0.89)

0.013

0.67 (0.47; 0.97)

0.032

0.67 (0.47; 0.96)

0.031

 Post-menopausal

49,229

1284

1.00 (ref)

0.83 (0.72; 0.96)

0.010

0.83 (0.72; 0.96)

0.011

0.81 (0.72; 0.93)

0.002a

0.82 (0.72; 0.93)

0.002a

Colorectal

94,656

862

1.00 (ref)

0.78 (0.66; 0.92)

0.004

0.79 (0.67; 0.93)

0.006

0.76 (0.65; 0.90)

0.001a

0.79 (0.66; 0.93)

0.005

 Colon

94,698

575

1.00 (ref)

0.69 (0.56; 0.85)

 < 0.001a

0.69 (0.57; 0.85)

0.001a

0.67 (0.55; 0.82)

 < 0.001a

0.69 (0.56; 0.84)

 < 0.001a

 Distal

94,734

242

1.00 (ref)

0.62 (0.46; 0.86)

0.003

0.62 (0.45; 0.85)

0.003

0.54 (0.39; 0.76)

 < 0.001a

0.56 (0.40; 0.77)

 < 0.001a

 Proximal

94,748

303

1.00 (ref)

0.77 (0.58; 1.02)

0.069

0.78 (0.59; 1.03)

0.084

0.75 (0.57; 1.00)

0.057

0.77 (0.58; 1.02)

0.067

 Rectum

94,734

342

1.00 (ref)

0.97 (0.74; 1.25)

0.789

0.99 (0.76; 1.28)

0.943

0.97 (0.74; 1.26)

0.798

1.01 (0.78; 1.32)

0.926

Lung

94,760

431

1.00 (ref)

0.92 (0.73; 1.15)

0.465

1.02 (0.81; 1.27)

0.895

0.67 (0.52; 0.85)

0.001a

0.80 (0.63; 1.02)

0.073

Kidney

94,754

221

1.00 (ref)

0.85 (0.62; 1.16)

0.299

0.85 (0.62; 1.17)

0.322

0.64 (0.45; 0.90)

0.011

0.64 (0.45; 0.92)

0.014

Pancreas

94,770

213

1.00 (ref)

0.72 (0.52; 1.01)

0.061

0.74 (0.53; 1.04)

0.076

0.73 (0.52; 1.01)

0.058

0.75 (0.53; 1.04)

0.087

Uterus

50,588

212

1.00 (ref)

1.00 (0.71; 1.40)

0.994

0.99 (0.71; 1.39)

0.964

0.84 (0.61; 1.16)

0.287

0.83 (0.60; 1.14)

0.250

Oesophagus

94,765

151

1.00 (ref)

0.89 (0.61; 1.29)

0.534

0.92 (0.63; 1.34)

0.665

0.60 (0.39; 0.92)

0.020

0.64 (0.41; 0.99)

0.046

Ovary

50,603

147

1.00 (ref)

0.69 (0.46; 1.03)

0.071

0.69 (0.46; 1.03)

0.070

0.57 (0.39; 0.84)

0.005

0.57 (0.39; 0.84)

0.005

Bladder

94,756

141

1.00 (ref)

0.70 (0.47; 1.06)

0.093

0.73 (0.48; 1.10)

0.135

0.67 (0.43; 1.03)

0.066

0.72 (0.47; 1.11)

0.137

Head and Neck

94,763

129

1.00 (ref)

1.45 (0.95; 2.22)

0.086

1.51 (0.98; 2.31)

0.060

1.42 (0.93; 2.18)

0.108

1.52 (0.99; 2.33)

0.057

Stomach

94,770

99

1.00 (ref)

1.01 (0.63; 1.62)

0.982

1.02 (0.64; 1.65)

0.920

0.94 (0.57; 1.54)

0.804

0.97 (0.59; 1.59)

0.899

Liver

94,773

82

1.00 (ref)

0.78 (0.46; 1.33)

0.364

0.80 (0.47; 1.35)

0.397

0.66 (0.38; 1.15)

0.142

0.68 (0.39; 1.18)

0.172

Gallbladder

94,777

49

1.00 (ref)

0.68 (0.34; 1.35)

0.269

0.67 (0.34; 1.33)

0.251

0.56 (0.27; 1.15)

0.115

0.54 (0.26; 1.12)

0.098

  1. Data are presented as hazard ratio (HR) with 95% confidence intervals in parentheses (95% CIs). Lowest score tertile was the reference group. Model 1 was adjusted for age, sex, Townsend deprivation index, and ethnicity. Model 2 was additionally adjusted for smoking status
  2. aFollowing correction using the Holm-Bonferroni method P < 0.05